NCT01419145已完成不适用
A Feasibility Study of Multimodal Exercise/Nutrition/Anti-inflammatory Treatment for Cachexia - the Pre-MENAC Study
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 46
- 试验地点
- 3
- 主要终点
- Feasibility of recruitment and retention
研究概览
简要总结
A multicentre, open, randomized phase II study comparing a multimodal intervention (oral nutritional supplements, celecoxib and physical exercise) for cachexia versus standard cancer care.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Main eligibility criteria:
- •Advanced non-small-cell lung cancer (stage III-IV) or pancreatic cancer not eligible for curative therapy
- •Due to commence chemo- or chemo radiotherapy
- •Karnofsky Performance Score ≥ 70
- •A life expectancy of ≥4 months and considered able to complete 2 months of the study
排除标准
- 未提供
研究组 & 干预措施
Multimodal intervention
Experimental
干预措施: Multimodal intervention (Other)
Standard Care
Active Comparator
干预措施: Standard care (Other)
结局指标
主要结局
Feasibility of recruitment and retention
时间窗: 12 weeks
The aim of this study is to investigate the feasibility of the multimodal intervention for cancer cachexia by assessing; enrolment rate, compliance with study intervention, contamination-rate in the control group with respect to any of the interventions.
次要结局
未报告次要终点
研究者
研究点 (3)
Loading locations...
相似试验
进行中（未招募）
1 期
A feasibility study of Multimodal Exercise/Nutrition/Anti-inflammatory treatment for Cachexia - the pre-MENAC study.MedDRA version: 16.0Level: LLTClassification code 10025044Term: Lung cancerSystem Organ Class: 100000004864lung cancerEUCTR2010-022897-14-DKSt. Olavs University Hospital12
进行中（未招募）
1 期
A study examining a combination of treatments (exercise, diet advice and anti-inflammatory medication) in the treatment of weight loss, fatigue and poor appetite in cancerNon-operable stage III/IV non-small cell lung cancer Pancreatic cancerMedDRA version: 20.0 Level: LLT Classification code 10025055 Term: Lung cancer non-small cell stage IV System Organ Class: 100000004864MedDRA version: 20.0 Level: LLT Classification code 10025052 Term: Lung cancer non-small cell stage III System Organ Class: 100000004864MedDRA version: 20.0 Level: LLT Classification code 10033604 Term: Pancreatic cancer System Organ Class: 100000004864EUCTR2010-022897-14-GBGreater Glasgow Health Board46
已完成
1 期
Feasibility study on nutrition and exercise intervention after gastrectomy for gastric cancerGastric cancerJPRN-UMIN000031262Cancer Institute Hospital, Japanese Foundation for Cancer Research50
已完成
不适用
A Feasibility study of the nutritional and exercise treatment for the elderly patients with advanced non-small-cell lung and pancreatic canceron-small-cell lung and pancreatic cancerJPRN-UMIN000023207Japan Agency for Medical Research and Development30
招募中
不适用
Exploring the Impact of a Multi-modal Nutritional Intervention in Patients Undergoing Chemotherapy for Pancreatic Cancer (FEED Trial)Pancreatic CancerNCT06149546Cancer Trials Ireland70